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The classical central macrophage found in erythroblastic islandsplays an important role in erythroblast differentiation, prolifera-tion and enucleation in the bone marrow. Convenient human in
vitro models to facilitate the study of erythroid-macrophage interactions
are desired. Recently, we demonstrated that cultured
monocytes/macrophages enhance in vitro erythropoiesis by supporting
hematopoietic stem and progenitor cell survival. Herein, we describe
that these specific macrophages also support erythropoiesis. Human
monocytes cultured in serum-free media supplemented with stem cell
factor, erythropoietin, lipids and dexamethasone differentiate towards
macrophages expressing CD16, CD163, CD169, CD206, CXCR4 and
the phagocytic TAM-receptor family. Phenotypically, they resemble
both human bone marrow and fetal liver resident macrophages. This dif-
ferentiation is dependent on glucocorticoid receptor activation.
Proteomic studies confirm that glucocorticoid receptor activation differ-
entiates monocytes to anti-inflammatory tissue macrophages with a M2
phenotype, termed GC-macrophages. Proteins involved in migration,
tissue residence and signal transduction/receptor activity are upregulated
whilst lysosome and hydrolase activity GO-categories are downregulat-
ed. Functionally, we demonstrate that GC-macrophages are highly
mobile and can interact to form clusters with erythroid cells of all differ-
entiation stages and phagocytose the expelled nuclei, recapitulating
aspects of erythroblastic islands. In conclusion, glucocorticoid-directed
monocyte differentiation to macrophages represents a convenient model
system to study erythroid-macrophage interactions. 
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ABSTRACT
Introduction
In human bone marrow (BM) and fetal liver (FL), the production of erythrocytes
through erythropoiesis occurs on erythroblastic islands.1,2 These erythroblastic
islands consist of a central macrophage surrounded by erythroid cells at different
stages of terminal differentiation and support proliferation, differentiation and
phagocytose the extruded nuclei (or pyrenocytes) of erythroid cells.2-6 Chow et al.
described that mouse CD169+ (SIGLEC1) BM resident macrophages display a dual
role promoting erythropoiesis and retention of hematopoietic stem and progenitor
cells (HSPC).7,8 Their absence leads to the mobilization of HSPC, reduced BM ery-
thropoiesis and the inability to properly respond to anemia.7-10 It is, however,
unclear whether CD169 identifies different macrophage populations or indicates an
intrinsic dual role for the same tissue macrophage. FL macrophages that are unable
to interact with erythroblasts due to disruption of the retinoblastoma tumor sup-
pressor gene in mice lead to embryonic death as erythrob-
lasts fail to enucleate.11 These data show that in vivo,
macrophages are important in regulating erythropoiesis in
adults and during development.
Previously, we found that blood-derived monocytes
induced to differentiate using stem cell factor (SCF), ery-
thropoietin (EPO) and glucocorticoids enhance in vitro ery-
thropoiesis by supporting HSPC survival.12 These
macrophages display a tissue-resident profile expressing
CD14 (lipopolysaccharide [LPS]-receptor), CD16 (FcγRIII),
scavenger receptor CD163, CD169, CD206 (mannose
receptor), CXCR4 and minimal expression of dendritic
cell-specific intercellular adhesion molecule 3-grabbing
non-integrin (DC-SIGN).12 We hypothesized that these
cultured monocyte-derived macrophages may have a sim-
ilar role as mouse CD169+ macrophages in both
hematopoiesis and erythropoiesis. This would provide an
easy-to-use in vitro human model system to mimic ery-
throblastic islands allowing for the study of functional
interactions between macrophages and erythroid cells,
which is currently limited to harvesting BM or involves
genetic modification.13 A better understanding of the
mechanism(s) through which human macrophages inter-
act and regulate erythroblast maturation and enucleation
is important in order to understand the pathology of ery-
thropoietic disorders, such as erythrocytosis in poly-
cythemia vera or erythrophagocytosis in several types of
hemolytic anemia, as well as to improve in vitro erythroid
differentiation protocols for erythrocyte production.14,15
In mice BM, erythroblasts are bound to macrophages via
interactions between integrin-α4β1 on erythroblasts and
VCAM1 on macrophages, and blocking these molecules
disrupts erythroblastic islands.16 Chow et al. described
human BM macrophages as also expressing VCAM1.
However, Ulyanova et al. have shown that Vcam-/- mice do
not display an erythroid phenotype during homeostasis or
phenylhydrazide-induced stress.17 During terminal differ-
entiation erythroblasts enucleate, resulting in reticulocytes
and pyrenocytes. The latter are also still encapsulated by
plasma membrane. In mice, clearance of pyrenocytes
occurs via TAM-receptors on the central macrophages that
recognize and bind phosphatidylserine (PS) exposed on
pyrenocytes resulting in phagocytosis in a protein S-
dependent manner.18,19 The TAM-receptor family of tyro-
sine kinases (TYRO3, AXL, and MERTK) play an impor-
tant role in the phagocytic ability of macrophages as triple
knock-out mice fail to clear apoptotic cells in multiple tis-
sues. These mice develop normally, but eventually devel-
op autoimmunity, such as systemic lupus erythematosus
(SLE).20 This is in line with studies showing that SLE has
been associated with failure of macrophages to phagocy-
tose apoptotic cells and pyrenocytes in both humans and
mice.21-24 In addition, anemia is found in about 50% of SLE
patients; Toda et al. showed that embryos suffer from
severe anemia caused by failure of macrophages to phago-
cytose pyrenocytes.25 These data indicate that
macrophages are essential during all stages of erythro-
poiesis, including enucleation, and display inherent fea-
tures that are indispensable to the functionality of these
macrophages.
Herein, we show that peripheral blood monocytes can
be differentiated to erythropoiesis-supporting
macrophages that interact with erythroid cells, phagocy-
tose pyrenocytes and phenotypically resemble human
CD169+ BM and FL macrophages.
Methods
Human materials
Human blood, BM and FL mononuclear cells were purified by
density separation, following manufacturer’s protocol. Regarding
blood, informed consent was given in accordance with the
Declaration of Helsinki, the Dutch National and Sanquin Internal
Ethic Boards, and by the Bristol Research Ethics Committee
(REC;  12/SW/0199). Following informed consent, adult BM aspi-
rates were obtained from the sternum of patients undergoing car-
diac surgery, and approved by the Medical Ethical Review Board
of the AMC (MEC:04/042#04.17.370). Fetal tissues (week 15-22)
were obtained from elective abortions contingent on informed
consent and approval by the Medical Ethical Commission of the
Erasmus University Medical Center Rotterdam (MEC-2006-202). 
Cell culture
CD14 and CD34 MicroBeads (Miltenyi Biotec, Gladbach,
Germany) were used for cell isolation from peripheral blood.
CD14+ monocytes were cultured at 1.5-3x106 cells/well (CASY®
Model TTC, Schärfe System GmbH, Reutlingen, Germany) in a
12-well plate as described.12 Cells were treated with 1-20μM
mifepristone (Sigma-Aldrich, Munich, Germany) directly after
isolation or 4-24 hours after three days of culture. CD34+ cells
were differentiated towards erythroblasts,12 with the addition of
1ng/ml IL-3 (R&D systems, Abingdon, UK) at the start of culture.
Media was replenished every two days. After 8-10 days, cells
were differentiated towards reticulocytes by removing dexam-
ethasone, increasing EPO (10U/ml, ProSpec; East Brunswick, NJ,
USA) and adding heparin (5U/ml, LEO Pharma B.V., Breda, The
Netherlands), 5% pooled AB+ plasma and holotransferrin
(700µg/ml, Sanquin, Amsterdam, The Netherlands). Every other
day, half the media was replenished. For co-culture experiments,
CD14+ cells were differentiated with (GC-macrophages) or with-
out  dexamethasone for three days and co-cultured with ery-
throblasts (day 8-10 of culture; ratio 1:1.5) or more differentiated
erythroid cells (day 6 of differentiation; ratio 1:4) for 24 hours.
Flow cytometry
Cells were washed in phosphate-buffered saline (PBS) and
resuspended in 1% bovine serum albumin (BSA)/PBS. Cells were
incubated with primary antibodies for 30min at 4C, measured on
LSRII or LSRFortessa (both BD Biosciences, Oxford, UK) and ana-
lyzed using FlowJo software (FlowJo v10; Tree Star, Inc.,
Ashland, OR, USA) (antibodies listed in Online Supplementary
Methods).
Mass spectrometry
See Online Supplementary Methods.
ImageStreamX and IncuCyte
GC-macrophages or unstimulated cells were incubated with
100μg/ml fluorescein isothiocyanate (FITC)-labeled zymosan (S.
cerevisiae; MP Biomedicals, Solon, OH, USA) for 40min at 37C.
Zymosan was removed and cells were fixed in 4% paraformalde-
hyde (PFA) for 20min at 4C. Cells were transferred to 1%
BSA/PBS and stained with human leukocyte antigen-antigen D-
related R-phycoerythrin (HLA-DR PE; BD Biosciences).
Furthermore, erythroid cells at day seven of differentiation were
stained with Deep Red Anthraquinone 5 (DRAQ5; Abcam,
Cambridge, UK). Imaging was performed on the ImageStreamX
(Amnis Corporation, Seattle, WA, USA) and images were ana-
lyzed using IDEAS Application v6.1 software (Amnis
Corporation). For IncuCyte experiments see Online Supplementary
Methods.
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Cytospins
Cells were cytospun using Shandon Cytospin II (Thermo
Scientific), dried and fixed in methanol. Cells were stained with
benzidine and Differential Quik Stain Kit (PolySciences,
Warrington, PA, USA) following manufacturer’s instructions.
Slides were dried, embedded in Entellan (Merck, Darmstadt,
Germany) and images were taken (Leica DM-2500, Germany).
Reverse transcription polymerase chain reaction 
analysis
Reverse transcription polymerase chain reaction (RT-PCR) was
performed as previously described.12 Values were normalized
using S18 and HPRT as a reference gene and calibrated relative to
expression of CD14+ monocytes at day 0 (primers listed in Online
Supplementary Methods).
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Figure 1. Glucocorticoid receptor activation directs CD14+ monocytes towards a tissue resident macrophage phenotype. (A-D) Distribution graphs displaying the
relative geometric mean fluorescence intensity (MFI) of CD16, CD163, CD169 and CXCR4 on human monocytes (n=3-6) cultured for three days under various con-
ditions (EPO, SCF, lipids or dexamethasone). MFI was normalized to change to isotype control and presented as fold change (fc). Mean ± SEM (two-way ANOVA,
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001). (E) Relative expression of CD16, CD163, CD169, CXCR4, CD206 and DC-SIGN on CD14+ monocytes (n=3)
directly after isolation from mononuclear cells (D0) and after culture in the presence or absence of dexamethasone (Dex) and/or mifepristone (Mif). MFI was nor-
malized to isotype control and displayed as a fold change to day 0. Mean ± SEM (ratio paired t-test, *P<0.05, **P<0.01). EPO: erythropoietin; SCF: stem cell factor;
ns: not significant; ND: not detected.
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Results
Glucocorticoid stimulation directs monocyte 
differentiation to CD16+CD163+CD169+CXCR4+CD206+
macrophages
We previously found that purified peripheral blood
CD14+ monocytes cultured in EPO, SCF, lipids and dexam-
ethasone differentiate within three days into CD163,
CD169, CXCR4 and CD16-positive macrophages that,
upon co-culture with CD34+ cells, significantly increase the
erythroid yield.12 However, it remained unclear as to which
growth factors were crucial to differentiate monocytes to
macrophages supporting erythropoiesis. Therefore, we
examined which growth factors or supplements deter-
mined this differentiation cue. Flow cytometry analysis
showed that dexamethasone, exclusively, induces high
expression of CD16 and CD163 in macrophages. The addi-
tion of EPO, SCF or lipids does not contribute to this high
expression (Figure 1A,B). CXCR4 expression was already
upregulated in the absence of dexamethasone but was fur-
ther increased upon stimulation with dexamethasone and
lipids, whilst the expression of tissue residency marker
CD169 was also upregulated but occurred in a dexametha-
sone-independent manner (Figure 1C,D). Online
E. Heideveld et al.
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Figure 2. Proteome analysis of CD14+ monocytes cultured in the presence or absence of dexamethasone revealed two distinct macrophage populations. (A)
Principal component analysis of GC-macrophages (red) versus non-glucocorticoid stimulated cells (blue) of four donors (indicated A-D). (B)  Volcano plot (false dis-
covery rate 0.05 S0 0.4) showing P-values (-log) versus difference of cells cultured for three days in the presence or absence of dexamethasone. (C) Heatmap of dif-
ferentially expressed proteins based on Z-scored label-free quantification values. (D) Interaction analysis based on STRING (all interactions) of upregulated (red) and
downregulated (blue) proteins. (E) Enrichment analysis using BiNGO and enrichment mapper in GC-macrophages with upregulated (red) and downregulated (blue)
processes.
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Supplementary Figure S1A depicts distinct morphological
changes upon dexamethasone-induced differentiation
between freshly isolated CD14+ monocytes and cultured
CD14+ cells. Monocytes were incubated with mifepris-
tone, which blocks glucocorticoid receptor activation.
Membrane and messenger ribonucleic acid (mRNA)
expression of CD16, CD163, and CD206 was significantly
reduced by mifepristone treatment, and thus dependent on
glucocorticoid receptor transcriptional control (Figure 1E
and Online Supplementary Figure S1B,C). Although neither
Figure 1C nor Figure 1E  show an effect of dexamethasone
on the fluorescence intensity of CD169, mRNA levels of
CD169 were clearly increased upon stimulation of the glu-
cocorticoid receptor and reduced when cells were treated
with mifepristone. In contrast, CXCR4 mRNA levels did
not change upon mifepristone treatment, but membrane
expression was increased (Online Supplementary Figure
S1B). Monocyte differentiation increases expression of
DC-SIGN independently of dexamethasone, albeit to
expression levels that are significantly lower compared to
dendritic cells (Figure 1E and Online Supplementary Figure
S1C).26 Note that cultured monocytes in all conditions are
a homogeneous population, as single peaks observed in
histograms and multi-color flow cytometry data revealed
that monocytes stimulated with glucocorticoids are
CD16+CD163+CD169+CXCR4+CD206+ cells (Online
Supplementary Figure S1C,D). Interestingly, flow cytometry
data revealed that monocytes that have been differentiated
for three days in the presence of dexamethasone were
unable to change their phenotype after 4 or 24 hours of
mifepristone treatment. Only CD163 expression was
slightly reduced after 24 hours mifepristone treatment
(Online Supplementary Figure S1E). The data indicates that
glucocorticoid stimulation initiates an irreversible differen-
tiation program of monocytes towards
CD16+CD163+CD169+CXCR4+CD206+ macrophages
which is maintained for at least 17 days of culture (Online
Supplementary Figure S2A,B).
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Figure 3. GC-macrophages form erythrob-
last clusters with increased frequency and
erythroblast composition. (A) Expression of
integrins ITGA4 and ITGB1 and adhesion
molecules ICAM1, PECAM, and VCAM1 on
GC-macrophages (Mφ) (n=6) and erythrob-
lasts (EBL) at day 1 and 7 of differentiation
(n=3-4). Mean fluorescence intensity (MFI)
has been normalized to the isotype control.
Mean ± SEM (unpaired t-test,  *P<0.05,
**P<0.01, ***P<0.001, ****P<0.0001).
(B) Scaled cell-displacement vector dia-
gram (left; 20 representative macrophages
in both conditions) and box-and-whisker
plot (right; 68 representative macrophages
in -Dex and 21 in +Dex) after three days of
culture in the absence or presence of dex-
amethasone. (Welch's unpaired t-test,
**P<0.01, n=5). (C-D) Co-culture of GC-
macrophages or unstimulated cells with
erythroblasts (unpaired t-test of 1153 
(-Dex) and 749 (+Dex) macrophages,
**P<0.01, ****P<0.0001, n=5). Images
were taken every hour during 64 hours of
analysis. (C) Plot showing the average ery-
throblast-macrophage links for each
macrophage. Mean ± SD. (D) 5-95% box
plot showing the maximum number of links
per macrophage. Mean is indicated by
crosses. (E) Representative images of
cytospins of GC-macrophages (+Dex) or
unstimulated cells (-Dex) co-cultured with
erythroblasts for 24 hours (in 50x magnifi-
cation, panels i-ii or 100x magnification,
panels iii-v; n=4). Dex: dexamethasone; ND:
not detected. 
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Proteomics data revealed GC-macrophages display a
distinct anti-inflammatory profile
To gain further insights into the dexamethasone-
induced monocyte differentiation process, we performed
mass spectrometry-based quantitative proteomics on
these cells after three days of differentiation and com-
pared this to non-glucocorticoid stimulated monocytes. A
total of 3,210 proteins were quantified, and principal com-
ponent analysis clearly separated glucocorticoid-stimulat-
ed from non-stimulated cells (Figure 2A and Online
Supplementary Table S1). Glucocorticoid stimulation
induced a distinct expression pattern compared to non-
glucocorticoid stimulated monocytes, as visualized in the
volcano plot and corresponding heatmap of the 169 differ-
entially expressed proteins for individual donors (Figure
2B,C). Note that the expression of CD163 and CD206
E. Heideveld et al.
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Figure 4. GC-macrophages can bind
erythroid cells and phagocytose
pyrenocytes. (A) Relative mRNA
expression of TAM-receptor family
members MERTK, AXL and TYRO3
on CD14+ cells (D0) cultured for
three days (D3) in the presence or
absence of dexamethasone (Dex).
20μM mifepristone (Mif) was added
for three days or after three days for
4 hours (n=4). Mean ± SEM (ratio
paired t-test, *P<0.05,
****P<0.0001). (B) Representative
ImageStreamX images of zymosan
(green) phagocytosed by HLA-DR
(red) positive unstimulated
macrophages (-Dex) and GC-
macrophages (+Dex) (left), and cor-
responding 10-90% box plot show-
ing the number of zymosan particles
phagocytosed (right) (unpaired t-test
of 1285 -Dex and 530 +Dex
macrophages, ****P<0.0001,
n=3). (C-F) GC-macrophages and
unstimulated cells were co-cultured
for 24 hours with day 6 differentiat-
ed erythroid cells (unpaired t-test of
370 –Dex and 313 +Dex
macrophages, ****P<0.0001,
n=3). (C) Representative images of
cytospins (in 50x magnification,
panels i-ii or 100x magnification,
panels iii-v). Macrophages bind
nucleated erythroid cells (large
arrow), reticulocytes (arrowhead)
and phagocytose pyrenocytes (small
arrow) and some erythroid cells dur-
ing differentiation (asterisk). 10-
90% box plots showing the number
of nucleated cells (D) or reticulo-
cytes (E) bound to macrophages
(Mφ). (F) Scatter plot showing the
number of pyrenocytes bound to or
phagocytosed by macrophages.
Mean ± SD. (G) Graph showing the
binding of CD235a+ differentiated
erythroid cells to GC-macrophages
versus unstimulated cells.
Corresponding histogram showing
geometric mean of CD235a in FITC
(n=4). Mean ± SEM (paired t-test,
**P<0.01). HLA-DR: human leuko-
cyte antigen – antigen D-related;
MFI: mean fluorescence intensity;
ns: not significant; BF: bright-field.
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(MRC1) was highly induced after glucocorticoid receptor
activation, corroborating the flow cytometry experiments.
The most differentially expressed proteins (n=169) were
mapped to evaluate specific upregulation or downregula-
tion of functionality-linked protein networks, based on
the Search Tool for the Retrieval of Interacting
Genes/Proteins (STRING) analysis (Figure 2D). CD163
and CD206 are part of an interactome protein node that is
specifically upregulated in dexamethasone-induced
macrophages, and includes M2 macrophage markers
CSF1R, stabilin-1 (STAB1) and complement proteins
C3AR1, C1QC, and FcγRIIa (CD32) which has been asso-
ciated with high phagocytic capacity of the cells.
Moreover, VSIG4 was upregulated in dexamethasone-
induced macrophages, which is restricted to resting tissue
macrophages,27 while ABCA1 was also upregulated,
which has been highly associated with hemoglobin-asso-
ciated macrophages.28 In addition, proteins with a positive
regulation of cell migration and motility, including DAB2,
ADAM9, Serpine1 (PAI1) and CD81, are upregulated in
dexamethasone-induced macrophages. Furthermore, a
whole range of signaling receptors were upregulated,
amongst which are TGF and IFNγ receptors (TGFBR1 and
IFNGR1) and IL13RA1. These proteins belong to process-
es that are enriched as GO-term, e.g., membrane part, sig-
nal transducer activity, transmembrane receptor activity
and molecular transduced activity. In addition, many
immune regulatory processes are also enriched (Figure 2E
and Online Supplementary Table S2). Interestingly, members
of the cathepsin family involved in antigen presentation
(e.g., CTSC, CTSL1, CTSD and CTSS) were downregulat-
ed. A range of pro-inflammatory proteins, clustered with-
in an interactome node, were downregulated; these
include lysosomal enzymes HEXA and HEXB, MANBA,
Modeling human erythroid-macrophage interactions
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Figure 5. CD163+ macrophage populations in human BM and FL. (A) Representative dot plots of erythroid cells characterized by the expression of CD71high and
CD235a in total human BM (n=4) and FL mononuclear cells (n=4). (B) Graph belonging to panel A. Mean ± SD (unpaired t-test, ***P<0.001). (C) Graph showing the
percentage of CD163+ cells present in the total cell population in BM (n=7) and FL (n=5). Mean ± SEM (unpaired t-test, **P<0.01). (D) Characterization of CD163+
macrophages in human BM (n=3-7) and FL (n=3-5) based on the expression of CD14, CD16, CD163, CD169, CXCR4, CD206 and VCAM1. Mean fluorescence intensity
(MFI) has been normalized to the isotype control. Mean ± SEM (unpaired t-test, **P<0.01). (E) Representative dot plots of erythroid-macrophage clusters formation
of erythroid cells (CD71highCD235a+) with CD163+ BM (n=4) and FL (n=4) macrophages. (F) Graph belonging to panel E. Mean ± SD (unpaired t-test, *P<0.05). BM:
bone marrow; FL: fetal liver.
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saponin PSAP and GLB1, in addition to other
lysosome/hydrolase activity-related GO-categories
(Figure 2D,E). In addition, GO-categories associated with
lipid metabolic processes were also downregulated in GC-
macrophages. Furthermore, CHI3L1 and CD44 are highly
upregulated in non-glucocorticoid stimulated cells (Figure
2B). CHI3L1 is described as a pro-inflammatory factor,29,30
while CD44  has been expressed on pro-inflammatory tis-
sue macrophages.31 In conclusion, CD14+ monocytes that
have been differentiated in the presence of dexametha-
sone display a distinct anti-inflammatory proteomic pro-
file and are further denoted as GC-macrophages, while
unstimulated cells have a more inflammatory profile.
GC-macrophages are motile and bind erythroblasts
GC-macrophages may, besides supporting the erythroid
yield, also regulate terminal differentiation of erythrob-
lasts, recapitulating aspects of erythroblastic islands. In
mice, it has been shown that BM central macrophages can
bind erythroblasts through various interactions: VCAM1-
integrin-α4β1,16,32 integrin-α5β1-ICAM4,33,34 erythroblast
macrophage protein (EMP)-EMP,4,35 or EphrinB2-
EphrinB4.36 Flow cytometry data revealed that GC-
macrophages express common cell adhesion molecules
(CAM), such as integrins (α4 [ITGA4], β1,2 [ITGB1,
ITGB2/CD18] and αL,M,X [ITGAL/CD11a,
ITGAM/CD11b, ITGAX/CD11c]), the immunoglobulin
(Ig) superfamily (ICAM1, PECAM, VCAM1) and E- and L-
selectin (Figure 3A and Online Supplementary Figure S3A).
Most of these CAM could be identified in the proteomics
data, including ICAM3, integrin-β5 and α5, however,
VCAM1, selectins and EMP were not detected (Online
Supplementary Table S1). With the exception of integrin-β5,
these CAM were not differentially expressed between
GC-macrophages and non-glucocorticoid stimulated cells.
Erythroblasts expressed similar ITGA4 levels compared to
GC-macrophages, but exhibited a 10-fold reduction in
ITGB1 expression and low expression of ICAM1 and
PECAM, whereas VCAM1 was not detected (Figure 3A).
When differentiating erythroblasts towards reticulocytes
(Online Supplementary Figure S3B,C), the expression of
CAM was reduced, as expected, which potentially indi-
cates a lower binding affinity of erythroid cells to
macrophages during erythroid differentiation. Next, we
investigated whether GC-macrophages interact in vitro
with erythroid cells compared to non-glucocorticoid stim-
ulated monocytes. Indeed, live imaging cells for 2.5 days
showed that GC-macrophages are highly motile and non-
stimulated macrophages are non-motile (Figure 3B), a
finding which corroborates the increased expression of
cell migration and motility proteins (Figure 2D) whilst
engaging twice as many erythroblasts (0.5 vs. 0.3,
P<0.0001) at every time point measured (Figure 3C,D). In
addition, cytospins of macrophages co-cultured for 24
hours with erythroblasts showed that the number of
macrophages binding erythroblasts as well as the number
of erythroblasts bound was increased on GC-
macrophages compared to non-GC macrophages (Figure
3E and Online Supplementary Figure S3D). Nonetheless, no
difference in interaction duration between erythroblasts
and macrophages from both conditions was observed
(Online Supplementary Figure S3E), suggesting that the
unstimulated cells possess some machinery to interact
with erythroblasts. In conclusion, GC-macrophages are
motile, express a variety of CAM and form erythroblast
interactions with increased frequency and numbers per
macrophage compared to cells cultured in the absence of
dexamethasone.  
GC-macrophages express TAM-receptor family 
members and phagocytose pyrenocytes
As CD169+CD163+ macrophages promote erythro-
poiesis,8 we decided to examine whether 
GC-macrophages can provide a similar functional role in
vitro. In mice, pyrenocytes are phagocytosed by central
macrophages in a Mer tyrosine kinase (MERTK)-depen-
dent manner.18 RT-PCR showed that GC-macrophages
upregulate both MERTK and AXL mRNA compared to
freshly isolated and non-glucocorticoid stimulated mono-
cytes (Figure 4A). MERTK expression was inhibited by
mifepristone treatment during the first three days of cul-
ture, whereas AXL was not, suggesting that AXL expres-
sion is induced via a trans-regulated process while MERTK
needs the transcriptional activity of the glucocorticoid
receptor. Note that TYRO3 levels are dexamethasone-
independently increased. Besides TAM-receptors, other
PS-receptors on macrophages have been reported to be
involved in clearing apoptotic bodies, such as TIM337
(T-cell Ig and mucin-domain containing-3), STAB38 and
CD300A39 (CMRF35-like molecule 8). TIM3 mRNA levels
were increased, albeit independently of dexamethasone
(Online Supplementary Figure S4A). This was confirmed by
mass spectrometry, as peptides corresponding to TIM3
were identified in GC-macrophages (HAVCR2 in Online
Supplementary Table S1). CD300A and STAB1 were also
identified, of which STAB1 was significantly increased in
GC-macrophages compared to unstimulated cells.
Interestingly, proteomics data showed that lactadherin, a
PS-binding glycoprotein which stimulates phagocytosis of
red blood cells by macrophages,40 was significantly
induced in GC-macrophages compared to unstimulated
cells. RT-PCR confirmed increased lactadherin mRNA lev-
els, but this was dexamethasone-independent (Online
Supplementary Figure S4B). Moreover, both GC-
macrophages and unstimulated cells express DNASE2, a
crucial protein required to degrade DNA within phagocy-
tosed apoptotic bodies or pyrenocytes in macrophages.41
Expression of TAM-receptors and other PS-receptors on
GC-macrophages may be a prerequisite to phagocytose
particles, cells or pyrenocytes in case of erythropoiesis.
Figure 4B shows that the number of GC-macrophages that
phagocytose particles, in addition to the amount of
zymosan particles per macrophage, is higher (73% vs.
45%, 2.3 vs. 1.7, respectively) compared to unstimulated
cells. Subsequently, both unstimulated cells and GC-
macrophages were co-cultured with a mixture of differen-
tiating erythroblasts, reticulocytes and pyrenocytes
(Online Supplementary Figure S3B,C) for 24 hours. Cytospin
analysis showed that both GC-macrophages and unstim-
ulated cells bind erythroid cells (Figure 4C), however,
increased numbers of nucleated cells, reticulocytes and
pyrenocytes bind to GC-macrophages compared to
unstimulated cells (Figure 4D-F and Online Supplementary
Figure S4C). Note that all nucleated erythroid cells are
specifically aligned with their nucleus towards the
macrophage as observed in vivo (Figure 4C). Pyrenocytes,
however, were almost solely phagocytosed by GC-
macrophages (Figure 4F and Online Supplementary Figure
S4D). Importantly, GC-macrophages and unstimulated
cells did not overtly phagocytose nucleated cells or reticu-
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locytes (Online Supplementary Figure S4E,F). Flow cytome-
try data showed that indeed both GC-macrophages and
unstimulated cells can bind erythroid cells, however,
increased cluster formation was found for GC-
macrophages compared to unstimulated cells (Figure 4G).
These results demonstrate that GC-macrophages func-
tionally resemble specific aspects of macrophages within
the erythroblastic island by binding erythroblasts and
reticulocytes and phagocytosing pyrenocytes. 
GC-macrophages share characteristics with CD163+
macrophages found in human BM and FL
To investigate whether GC-macrophages share pheno-
typical characteristics with macrophages found in the two
major erythropoietic organs during human development
and adulthood (FL and BM, respectively), mononuclear
cells of both organs were analyzed. Between week 15 and
22 of human development, the FL is primarily undertaking
erythropoiesis, representing a median of 85% of the total
number of mononuclear cells compared to 29% in BM,
with increased frequencies of CD71+CD235– pro-ery-
throblasts in FL (Figure 5A,B). To prevent the presence of
free immunogenic pyrenocytes and to support erythroid
cell requirements in the developing embryo, it is anticipat-
ed that the FL contains significant amounts of erythroblas-
tic islands and, thus, supporting macrophages. Indeed,
Figure 5C shows a 6.5-fold increase in CD163+ FL
macrophages compared to BM (3.3% vs. 0.5%). Further
characterization shows only subtle differences in expres-
sion of macrophage markers (Figure 5D and Online
Supplementary Figure S5A,B), as both macrophage popula-
tions express high levels of CD163 and CD14 and have
intermediate levels of CD169, CD206 and VCAM1.
CD163+ BM macrophages tend to express more CXCR4,
whereas CD163+ FL macrophages have higher expression
of CD16. Online Supplementary Table S3 displays the com-
parison between the mean fluorescence intensity (MFI) of
BM, FL, non-stimulated and GC-macrophages and reveals
that GC-macrophages phenotypically recapitulate
macrophages found in the FL and BM. GC-macrophages
are more similar to BM macrophages (CD16 and CXCR4
expression), however, they also share features of FL
macrophages (CD206 expression). Unstimulated cells do
not express VCAM1, and have low expression of CD206,
CD163, CD14 and CD16. Figure 5E,F shows that both BM
and FL CD163+ macrophages bind erythroid cells (46% in
BM vs. 83% in FL), indicating that CD163 purifies ery-
throid-supporting macrophages. Interestingly, FL
macrophages have increased interactions with
CD71+CD235a+ cells compared to BM. The similarity of
marker expression levels of BM, FL and GC-macrophages
and the fact that all three populations form erythroid clus-
ters suggest that GC-macrophages share phenotypic and
functional characteristics with in vivo erythroid-supporting
macrophages. GC-macrophages could thus be used as a
substitute in vitro model to study the supportive effects of
macrophages on erythropoiesis.
Discussion 
We have previously shown that monocyte-derived
macrophages can support erythropoiesis by increased sur-
vival of HSPC.12 Herein, we show that these macrophages,
derived from CD14+ monocytes, are differentiated in a glu-
cocorticoid-dependent manner (termed GC-
macrophages), interact with erythroid cells of all stages
and phagocytose the extruded pyrenocytes. Besides these
functional aspects, GC-macrophages also share phenotyp-
ic characteristics with resident macrophages from both
human BM and FL, among which there is high expression
of CD163 and CD206. Interestingly, CD163+ BM cells
appear to be more heterogeneous compared to FL cells.
GC-macrophages also phenotypically resemble
macrophages described recently by Belay et al., who
employed a lentivirally introduced small molecule respon-
sive Mpl-based cell growth switch that enabled cord
blood or BM CD34+ cells to be differentiated to erythroid-
supporting macrophages.13 Similar to GC-macrophages,
these cells express CD14, CD163, CD169, CD206,
VCAM1, ITGAM and ITGAX. Herein, we show that
these macrophages can also be differentiated from periph-
eral blood monocytes using dexamethasone, without the
need for genetic manipulation. Falchi et al. showed that in
erythroid culture conditions, CD34+ cells can also differen-
tiate to macrophages that interact with erythroid cells,
however, we can exclude this differentiation pathway as
the purified CD14+ monocytes we used to differentiate
macrophages from peripheral blood did not show
hematopoietic colony potential or CD34+ contamination.12 
The erythroid system is renowned for its rapid response
to systemic decreases in oxygen pressure. Together with
elevated EPO levels, glucocorticoid levels also increase
upon exposure to high altitude.42 EPO, SCF and glucocor-
ticoids induce erythroblasts to proliferate whilst inhibiting
differentiation.43-46 Elevated systemic EPO and glucocorti-
coids as a response to low-oxygen stress leads to increased
erythroid output due to augmented survival and prolifera-
tion of BM erythroblasts. To accommodate this increased
erythropoiesis, we hypothesize that the number of central
macrophages must also be increased or alternatively these
cells would have to engage with more erythroblasts. 
Our flow cytometry and cytospin data confirmed that
GC-macrophages interact with erythroid cells of all
stages, be that as it may, this does not provide information
on the longevity of the interactions, as these could be tran-
sient, as previously implied.47 Via live cell imaging we ana-
lyzed the interaction between GC-macrophages and ery-
throblasts, which revealed that GC-macrophages are
more mobile compared to cells that were cultured in the
absence of dexamethasone, and that this mobility, or
“macrophage ranging”, results in more interactions with
erythroblasts. Higher mobility was accompanied by an
increased expression of proteins involved in migration and
motility. High motility has previously been observed in
CD34+ differentiated macrophages stimulated with dex-
amethasone.47 Motility is an important functional aspect,
as erythroblastic islands in vivo form away from sinusoids
and migrate to the sinusoidal endothelium to release retic-
ulocytes into the circulation.48,49 Interestingly, this work
also demonstrates that non-glucocorticoid-stimulated
monocytes can interact with erythroblasts, as they form
interactions for the same length of time (1.8 hours on aver-
age) when they encounter erythroblasts. This suggests
that both populations express receptors that allow engage-
ment and interaction with erythroblasts, however, GC-
macrophages have significantly more interactions with
erythroblasts per macrophage and bind a higher number
of erythroblasts. Surprisingly, GC-macrophages display
low expression of VCAM1, suggesting that erythroblast
Modeling human erythroid-macrophage interactions
haematologica | 2018; 103(3) 403
interactions may also occur in a VCAM1-independent
manner. Indeed, Ulyanova et al. reported that Vcam1-/-
mice do not display a compromised erythroid stress
response in spleen and BM.17 Whether another interaction
substitutes for VCAM1 would need to be determined. The
presented monocyte differentiation methodology has
potential to be exploited as an imaging platform to delin-
eate the hierarchy of contributions of various receptors
within the macrophage-erythroblasts in BM and GC-
macrophages in future studies. 
We have also demonstrated, using proteomics and
imaging, that GC-macrophages actively phagocytose
pyrenocytes and express the correct putative machinery to
recognize pyrenocytes. The mechanism(s) through which
macrophages recognize reticulocytes but phagocytose
pyrenocytes are ill-defined in human erythropoiesis. Our
proteomic study and RT-PCR data demonstrate that GC-
macrophages express all TAM-receptors, including
MERTK and other PS-receptors, which may be used by
GC-macrophages to take up pyrenocytes. This work,
alongside our ability to manipulate erythroblast protein
expression, now provides an excellent accessible model
system to mechanistically understand how macrophages
promote erythropoiesis and eventually target pyrenocytes
for phagocytosis and destruction. Furthermore, it is inter-
esting to note that GC-macrophages interact preferably to
the polarized nuclear side of erythroid cells as observed in
BM erythroblastic islands. In general, proteomic analysis
revealed an array of processes and proteins that are differ-
entially regulated between GC-macrophages and unstim-
ulated cells. The data will allow further studies to delin-
eate essential pathways that are key to glucocorticoid-
stimulated differentiation of monocytes towards ery-
throid-supporting GC-macrophages. This is probably the
concerted action of multiple pathways. 
Finally, our observations have important implications
for our understanding of the dynamics of the macrophage
populations in human BM. We characterized both human
BM and FL macrophages and found that CD163+ FL
macrophages define a homogeneous population. In con-
trast, CD163+ BM macrophages show a more heteroge-
neous population, reflecting that CD163+ cells represent a
mixed population of myeloid cells. Both human BM and
FL CD163+ macrophages are capable of binding erythroid
cells, however, this percentage is lower in BM (46%) com-
pared to FL (83%). The FL is primarily performing erythro-
poiesis at week 15-22 of embryonic development, which
suggests that CD163 purifies mainly central macrophages.
The reduced erythroid-macrophage clusters in BM may
reflect a more heterogeneous CD163+ population with
possibly different functions. Changes observed in marker
expression of macrophages in both organs could thus be
due to this heterogeneity in the BM population. CD163
isolation in combination with single cell RNA-sequencing
may discriminate these different populations and identify
specific discriminatory cell surface markers to allow for
functional experiments.
Albeit for decades it was believed that all macrophages
originate from monocytes,50 recent parabiosis and fate-
mapping studies showed that most resident macrophages
are maintained independently of monocytes.51 However,
Theurl et al. showed that resident Kupffer cells in the liver
contain a mixture of de novo hematopoiesis-derived and
embryonic-derived macrophages. They identified an on-
demand mechanism to facilitate quick and transient
increases in cells that can function as Kupffer cells but orig-
inate from classical monocytes.52 Taken together with our
work, we hypothesize a new scenario in which specific
macrophages originate from different sources depending
on the need of a specific tissue or process. These processes
may also occur in other tissues in response to stress, like
the BM. The origin and homeostasis of human BM resi-
dent macrophages is presently ill-defined, if described at
all. Elevated glucocorticoid levels may lead to direct differ-
entiation of monocytes and elevated numbers of nursing
central macrophages to facilitate the increased erythroid
output in analogy to Kupffer cells. Active research is aimed
at unraveling the origin of tissue resident macrophages,
which is important in order to understand not only home-
ostatic but also pathogenic erythropoiesis in which a driv-
ing role of macrophages has been implicated, such as poly-
cythemia vera and β-thalassemia. Herein, we provide evi-
dence that monocytes can indeed differentiate in vitro to
macrophages that support erythropoiesis, providing a
model to study such erythroid-macrophage interactions. 
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